2009 H1N1 pandemic vaccine

GPTKB entity

Predicate	Object
gptkbp:instanceOf	vaccine
gptkbp:administeredBy	injection nasal spray
gptkbp:approvedBy	gptkb:World_Health_Organization gptkb:U.S._Food_and_Drug_Administration
gptkbp:category	pandemic vaccine
gptkbp:contains	gptkb:virus live attenuated virus antigen from A/California/7/2009 (H1N1) virus
gptkbp:developedBy	2009 H1N1 influenza virus
gptkbp:distributionBegan	September 2009
gptkbp:effect	prevents H1N1 influenza infection
gptkbp:form	one or two doses depending on age
https://www.w3.org/2000/01/rdf-schema#label	2009 H1N1 pandemic vaccine
gptkbp:introducedIn	2009
gptkbp:producedBy	gptkb:Sanofi_Pasteur gptkb:MedImmune gptkb:Novartis gptkb:CSL_Limited GlaxoSmithKline
gptkbp:recommendation	gptkb:Centers_for_Disease_Control_and_Prevention gptkb:World_Health_Organization
gptkbp:relatedTo	seasonal influenza vaccine
gptkbp:sideEffect	fever fatigue headache soreness at injection site
gptkbp:storage	refrigerated
gptkbp:targetAudience	children pregnant women healthcare workers general population
gptkbp:type	monovalent vaccine
gptkbp:usedDuring	gptkb:2009_H1N1_pandemic
gptkbp:bfsParent	gptkb:NYMC_X-179A gptkb:X-179A_reassortant_virus
gptkbp:bfsLayer	8